Horizon
Horizon in December announced it would delay new patients from starting Tepezza treatment to conserve supply for existing users.
Invoking the Defense Production Act is helping increase supply of badly needed COVID-19 vaccines, bringing the U.S. one step closer to ending the pandemic but as one local drug company has learned, there s a catch.
The government mandate to prioritize vaccine production at a biologics manufacturing facility has led to a shortage of Horizon Therapeutics top-selling product, a new remedy for thyroid eye disease. Tepezza was on track for $850 million in sales last year, until contract manufacturer Catalent was forced to stop making the intravenous drug.
Safeguarding Arab music: A new exhibition in the French port city of Marseilles - Culture - Al-Ahram Weekly
ahram.org.eg - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ahram.org.eg Daily Mail and Mail on Sunday newspapers.
Safeguarding Arab music - Culture - Al-Ahram Weekly
ahram.org.eg - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ahram.org.eg Daily Mail and Mail on Sunday newspapers.